Emerging evidence has indicated that lncATB can promote cancer cell invasion and metastasis in a variety of cancer cells by acting as a competitive endogenous RNA (ceRNA) that acts as a sponge and modulates the functions of the miR-200 family by enhancing the expression of miR-200 target genes, such as ZEB1, ZEB2 or TGF-β232,34,42,43. Here, ZEB1 is linked to cancer.